Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis

FEBS Letters

Volumn 585, Issue 23, 2011, Pages 3758-3763

  Saxena, A ^a,b   Martin Blondel, G ^a,b   Mars, L T ^a,b   Liblau, R S ^a,b  

^a CHU PURPAN   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Autoimmunity; CD8 T cell; Central nervous system; Experimental autoimmune encephalomyelitis; Multiple sclerosis

Indexed keywords

CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; GLATIRAMER; HLA A3 ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; EFFECTOR CELL; HUMAN; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REMISSION; REVIEW;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; LYMPHOCYTE SUBSETS; MODELS, IMMUNOLOGICAL; MULTIPLE SCLEROSIS; T-LYMPHOCYTES, REGULATORY;

ANIMALIA;

EID: 81755173556     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.08.047     Document Type: Review

References (98)

1. A. Compston, and A. Coles Multiple sclerosis Lancet 372 2008 1502 1517
2. M. Sospedra, and R. Martin Immunology of multiple sclerosis Annu. Rev. Immunol. 23 2005 683 747 (Pubitemid 40563183)
3. M.R. Lincoln A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis Nat. Genet. 37 2005 1108 1112 (Pubitemid 41486664)
4. S. Sawcer Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 2011 214 219
5. J.W. Lindsey, S. Hodgkinson, R. Mehta, D. Mitchell, D. Enzmann, and L. Steinman Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis Ann. Neurol. 36 1994 183 189 (Pubitemid 24239235)
6. B.W. Van Oosten Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial Neurology 49 1997 351 357
7. A.J. Coles, D.A. Compston, K.W. Selmaj, S.L. Lake, S. Moran, D.H. Margolin, K. Norris, and P.K. Tandon Alemtuzumab vs. interferon beta-1a in early multiple sclerosis N. Engl. J. Med. 359 2008 1786 1801
8. L. Fugger, M.A. Friese, and J.I. Bell From genes to function: the next challenge to understanding multiple sclerosis Nat. Rev. Immunol. 9 2009 408 417
9. A. Fogdell-Hahn, A. Ligers, M. Gronning, J. Hillert, and O. Olerup Multiple sclerosis: A modifying influence of HLA class I genes in an HLA class II associated autoimmune disease Tissue Antigens 55 2000 140 148 (Pubitemid 30103439)
10. H.F. Harbo Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis Tissue Antigens 63 2004 237 247 (Pubitemid 38297258)
11. B. Brynedal, K. Duvefelt, G. Jonasdottir, I.M. Roos, E. Akesson, J. Palmgren, and J. Hillert HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis PLoS ONE 2 2007 e664
12. N. Zhang, and M.J. BeVan CD8(+) T cells: foot soldiers of the immune system Immunity 35 2011 161 168
13. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
14. J.M. Curtsinger, C.S. Schmidt, A. Mondino, D.C. Lins, R.M. Kedl, M.K. Jenkins, and M.F. Mescher Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells J. Immunol. 162 1999 3256 3262 (Pubitemid 29313572)
15. M.J. Van Stipdonk, E.E. Lemmens, and S.P. Schoenberger Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation Nat. Immunol. 2 2001 423 429 (Pubitemid 33706140)
16. S. Sad, R. Marcotte, and T.R. Mosmann Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines Immunity 2 1995 271 279
17. M. Huber A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity Eur. J. Immunol. 39 2009 1716 1725
18. M.J. McGeachy The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo Nat. Immunol. 10 2009 314 324
19. D. Masopust, V. Vezys, A.L. Marzo, and L. Lefrancois Preferential localization of effector memory cells in nonlymphoid tissue Science 291 2001 2413 2417 (Pubitemid 32231804)
20. B.S. Sheridan, and L. Lefrancois Regional and mucosal memory T cells Nat. Immunol. 12 2011 485 491
21. J.C. Dudda, J.C. Simon, and S. Martin Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets J. Immunol. 172 2004 857 863 (Pubitemid 38113742)
22. L. Liu, R.C. Fuhlbrigge, K. Karibian, T. Tian, and T.S. Kupper Dynamic programming of CD8+ T cell trafficking after live viral immunization Immunity 25 2006 511 520 (Pubitemid 44354216)
23. L. Chavez-Galan, M.C. Arenas-Del Angel, E. Zenteno, R. Chavez, and R. Lascurain Cell death mechanisms induced by cytotoxic lymphocytes Cell. Mol. Immunol. 6 2009 15 25
24. M.K. Slifka, F. Rodriguez, and J.L. Whitton Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells Nature 401 1999 76 79
25. T. Hayashi, C. Morimoto, J.S. Burks, C. Kerr, and S.L. Hauser Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens Ann. Neurol. 24 1988 523 531
26. R.M. Ransohoff, and M.L. Estes Astrocyte expression of major histocompatibility complex gene products in multiple sclerosis brain tissue obtained by stereotactic biopsy Arch. Neurol. 48 1991 1244 1246
27. S.J. Gobin, L. Montagne, M. Van Zutphen, P. Van Der Valk, P.J. Van Den Elsen, and C.J. De Groot Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions Glia 36 2001 68 77
28. C. Beauvillain Neonatal and adult microglia cross-present exogenous antigens Glia 56 2008 69 77 (Pubitemid 350172732)
29. U. Traugott, E.L. Reinherz, and C.S. Raine Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages J. Neuroimmunol. 4 1983 201 221 (Pubitemid 13075816)
30. H. Babbe Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction J. Exp. Med. 192 2000 393 404 (Pubitemid 30629164)
31. J.M. Frischer The relation between inflammation and neurodegeneration in multiple sclerosis brains Brain 132 2009 1175 1189
32. S.L. Hauser, A.K. Bhan, F. Gilles, M. Kemp, C. Kerr, and H.L. Weiner Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions Ann. Neurol. 19 1986 578 587 (Pubitemid 16085192)
33. A. Junker Multiple sclerosis: T-cell receptor expression in distinct brain regions Brain 130 2007 2789 2799 (Pubitemid 350033964)
34. H. Neumann, I.M. Medana, J. Bauer, and H. Lassmann Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases Trends Neurosci. 25 2002 313 319 (Pubitemid 34667013)
35. A. Bitsch, J. Schuchardt, S. Bunkowski, T. Kuhlmann, and W. Bruck Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation Brain 123 Pt 6 2000 1174 1183 (Pubitemid 30312109)
36. T. Kuhlmann, G. Lingfeld, A. Bitsch, J. Schuchardt, and W. Bruck Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time Brain 125 2002 2202 2212
37. M. Jacobsen Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients Brain 125 2002 538 550 (Pubitemid 34194409)
38. T. Tsuchida, K.C. Parker, R.V. Turner, H.F. McFarland, J.E. Coligan, and W.E. Biddison Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides Proc. Natl. Acad. Sci. USA 91 1994 10859 10863
39. K. Honma, K.C. Parker, K.G. Becker, H.F. McFarland, J.E. Coligan, and W.E. Biddison Identification of an epitope derived from human proteolipid protein that can induce autoreactive CD8+ cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism J. Neuroimmunol. 73 1997 7 14 (Pubitemid 27105264)
40. A. Dressel, J.L. Chin, A. Sette, R. Gausling, P. Hollsberg, and D.A. Hafler Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands J. Immunol. 159 1997 4943 4951 (Pubitemid 127471031)
41. M.P. Crawford High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay Blood 103 2004 4222 4231 (Pubitemid 38685367)
42. Y.C. Zang, S. Li, V.M. Rivera, J. Hong, R.R. Robinson, W.T. Breitbach, J. Killian, and J.Z. Zhang Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis J. Immunol. 172 2004 5120 5127 (Pubitemid 38456441)
43. L. Berthelot Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals Eur. J. Immunol. 38 2008 1889 1899
44. A. Jurewicz, W.E. Biddison, and J.P. Antel MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes J. Immunol. 160 1998 3056 3059 (Pubitemid 28136763)
45. J.S. Tzartos, M.A. Friese, M.J. Craner, J. Palace, J. Newcombe, M.M. Esiri, and L. Fugger Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis Am. J. Pathol. 172 2008 146 155 (Pubitemid 351186376)
46. V. Annibali CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis Brain 134 2011 542 554
47. A. Reboldi C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE Nat. Immunol. 10 2009 514 523
48. S. Jilek, M. Schluep, A.O. Rossetti, L. Guignard, G. Le Goff, G. Pantaleo, and R.A. Du Pasquier CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis Clin. Immunol. 123 2007 105 113 (Pubitemid 46401506)
49. P. Kivisakk Expression of CCR7 in multiple sclerosis: implications for CNS immunity Ann. Neurol. 55 2004 627 638 (Pubitemid 38544322)
50. G.F. Debes, C.N. Arnold, A.J. Young, S. Krautwald, M. Lipp, J.B. Hay, and E.C. Butcher Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues Nat. Immunol. 6 2005 889 894 (Pubitemid 43090443)
51. S.K. Bromley, S.Y. Thomas, and A.D. Luster Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics Nat. Immunol. 6 2005 895 901 (Pubitemid 43090444)
52. M. Brahic, J.F. Bureau, and T. Michiels The genetics of the persistent infection and demyelinating disease caused by Theiler's virus Annu. Rev. Microbiol. 59 2005 279 298 (Pubitemid 41507433)
53. C. Munz, J.D. Lunemann, M.T. Getts, and S.D. Miller Antiviral immune responses: triggers of or triggered by autoimmunity? Nat. Rev. Immunol. 9 2009 246 258
54. I. Medana, M.A. Martinic, H. Wekerle, and H. Neumann Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes Am. J. Pathol. 159 2001 809 815 (Pubitemid 32847171)
55. T. Wang Granzyme B mediates neurotoxicity through a G-protein-coupled receptor FASEB J. 20 2006 1209 1211
56. E.S. Huseby, D. Liggitt, T. Brabb, B. Schnabel, C. Ohlen, and J. Goverman A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis J. Exp. Med. 194 2001 669 676 (Pubitemid 32844776)
57. D. Sun, J.N. Whitaker, Z. Huang, D. Liu, C. Coleclough, H. Wekerle, and C.S. Raine Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice J. Immunol. 166 2001 7579 7587 (Pubitemid 32525639)
58. M.L. Ford, and B.D. Evavold Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis Eur. J. Immunol. 35 2005 76 85 (Pubitemid 40123854)
59. A. Ben-Nun, N. Kerlero de Rosbo, N. Kaushansky, M. Eisenstein, L. Cohen, J.F. Kaye, and I. Mendel Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice Eur. J. Immunol. 36 2006 478 493 (Pubitemid 43257471)
60. M.D. Leech, A. Carrillo-Vico, R.S. Liblau, and S.M. Anderton Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8+ T cells derived from autoantigen-deficient mice Front. Immunol. 2 2011 17
61. D.J. Morgan, R. Liblau, B. Scott, S. Fleck, H.O. McDevitt, N. Sarvetnick, D. Lo, and L.A. Sherman CD8(+) T cell-mediated spontaneous diabetes in neonatal mice J. Immunol. 157 1996 978 983
62. A. Saxena Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes J. Immunol. 181 2008 1617 1621
63. S.Y. Na, Y. Cao, C. Toben, L. Nitschke, C. Stadelmann, R. Gold, A. Schimpl, and T. Hunig Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system Brain 131 2008 2353 2365
64. B. Sobottka, M.D. Harrer, U. Ziegler, K. Fischer, H. Wiendl, T. Hunig, B. Becher, and N. Goebels Collateral bystanDer damage by myelin-directed CD8+ T cells causes axonal loss Am. J. Pathol. 175 2009 1160 1166
65. S.Y. Na, H. Eujen, K. Gobel, S.G. Meuth, K. Martens, H. Wiendl, and T. Hunig Antigen-specific blockade of lethal CD8 T-cell mediated autoimmunity in a mouse model of multiple sclerosis J. Immunol. 182 2009 6569 6575
66. M.A. Friese Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis Nat. Med. 14 2008 1227 1235
67. L.T. Mars CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A0201-transgenic mice J. Immunol. 179 2007 5090 5098
68. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono Regulatory T cells and immune tolerance Cell 133 2008 775 787 (Pubitemid 351707693)
69. L. Cosmi Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes Blood 102 2003 4107 4114 (Pubitemid 37486995)
70. E. Xystrakis, A.S. Dejean, I. Bernard, P. Druet, R. Liblau, D. Gonzalez-Dunia, and A. Saoudi Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation Blood 104 2004 3294 3301 (Pubitemid 39507148)
71. L.B. Jarvis, M.K. Matyszak, R.C. Duggleby, J.C. Goodall, F.C. Hall, and J.S. Gaston Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function Eur. J. Immunol. 35 2005 2896 2908 (Pubitemid 41555085)
72. M. Rifa'i, Y. Kawamoto, I. Nakashima, and H. Suzuki Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis J. Exp. Med. 200 2004 1123 1134 (Pubitemid 39507052)
73. U. Feger, E. Tolosa, Y.H. Huang, A. Waschbisch, T. Biedermann, A. Melms, and H. Wiendl HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation Blood 110 2007 568 577 (Pubitemid 47105395)
74. N. Najafian Regulatory functions of CD8+CD28- T cells in an autoimmune disease model J. Clin. Invest. 112 2003 1037 1048 (Pubitemid 38056319)
75. M. Rifa'i, Z. Shi, S.Y. Zhang, Y.H. Lee, H. Shiku, K. Isobe, and H. Suzuki CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells Int. Immunol. 20 2008 937 947 (Pubitemid 351865868)
76. A.T. Endharti Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells J. Immunol. 175 2005 7093 7097 (Pubitemid 41713400)
77. H. Wiendl Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity Brain 128 2005 2689 2704 (Pubitemid 41552952)
78. C.T. Mayer, S. Floess, A.M. Baru, K. Lahl, J. Huehn, and T. Sparwasser CD8(+) Foxp3(+) T cells share developmental and phenotypic features with classical CD4(+) Foxp3(+) regulatory T cells but lack potent suppressive activity Eur. J. Immunol. 41 2011 716 725
79. I. Menager-Marcq, C. Pomie, P. Romagnoli, and J.P. Van Meerwijk CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice Gastroenterology 131 2006 1775 1785 (Pubitemid 44970462)
80. C.C. Chang Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4 Nat. Immunol. 3 2002 237 243 (Pubitemid 34218114)
81. G. Vlad, R. Cortesini, and N. Suciu-Foca License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC J. Immunol. 174 2005 5907 5914 (Pubitemid 40663774)
82. A. Varthaman Control of T cell reactivation by regulatory Qa-1-restricted CD8+ T cells J. Immunol. 184 2010 6585 6591
83. B.A. Sullivan, P. Kraj, D.A. Weber, L. Ignatowicz, and P.E. Jensen Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin Immunity 17 2002 95 105 (Pubitemid 34874622)
84. H.J. Kim, B. Verbinnen, X. Tang, L. Lu, and H. Cantor Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance Nature 467 2010 328 332
85. E. Uss, A.T. Rowshani, B. Hooibrink, N.M. Lardy, R.A. Van Lier, and I.J. ten Berge CD103 is a marker for alloantigen-induced regulatory CD8+ T cells J. Immunol. 177 2006 2775 2783 (Pubitemid 44277792)
86. S.D. Koch, E. Uss, R.A. Van Lier, and I.J. ten Berge Alloantigen-induced regulatory CD8+CD103+ T cells Hum. Immunol. 69 2008 737 744
87. H. Jiang, S.I. Zhang, and B. Pernis Role of CD8+ T cells in murine experimental allergic encephalomyelitis Science 256 1992 1213 1215
88. D. Hu, K. Ikizawa, L. Lu, M.E. Sanchirico, M.L. Shinohara, and H. Cantor Analysis of regulatory CD8 T cells in Qa-1-deficient mice Nat. Immunol. 5 2004 516 523 (Pubitemid 38660464)
89. A. Varthaman Physiological induction of regulatory Qa-1-restricted CD8+ T cells triggered by endogenous CD4+ T cell responses PLoS ONE 6 2011 e21628
90. Y.H. Lee, Y. Ishida, M. Rifa'i, Z. Shi, K. Isobe, and H. Suzuki Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis J. Immunol. 180 2008 825 832
91. J. Antel, M. Bania, A. Noronha, and S. Neely Defective suppressor cell function mediated by T8+ cell lines from patients with progressive multiple sclerosis J. Immunol. 137 1986 3436 3439 (Pubitemid 17193296)
92. M.B. Bania, J.P. Antel, A.T. Reder, M.K. Nicholas, and B.G. Arnason Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2 J. Clin. Invest. 78 1986 582 586 (Pubitemid 16074098)
93. A.L. Zozulya, and H. Wiendl The role of regulatory T cells in multiple sclerosis Nat. Clin. Pract. Neurol. 4 2008 384 398 (Pubitemid 352003290)
94. J. Correale, and A. Villa Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis J. Neuroimmunol. 195 2008 121 134
95. R. Liblau Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role J. Neurol. Sci. 287 Suppl. 1 2009 S17 S23
96. N.J. Karandikar Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis J. Clin. Invest. 109 2002 641 649 (Pubitemid 34204843)
97. D.K. Tennakoon, R.S. Mehta, S.B. Ortega, V. Bhoj, M.K. Racke, and N.J. Karandikar Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis J. Immunol. 176 2006 7119 7129 (Pubitemid 43787894)
98. L. Airas, T. Nikula, Y.H. Huang, R. Lahesmaa, and H. Wiendl Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G J. Neuroimmunol. 187 2007 205 211 (Pubitemid 47008932)